L97 Stock Overview
Provides hair-related healthcare services in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Yonghe Medical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.10 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.06 |
| Beta | 0.38 |
| 1 Month Change | 17.71% |
| 3 Month Change | -10.43% |
| 1 Year Change | -55.22% |
| 3 Year Change | -94.12% |
| 5 Year Change | n/a |
| Change since IPO | -94.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| L97 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.0% | 0.9% | 0.5% |
| 1Y | -55.2% | 18.0% | 7.2% |
Return vs Industry: L97 underperformed the German Healthcare industry which returned 18% over the past year.
Return vs Market: L97 underperformed the German Market which returned 7.2% over the past year.
Price Volatility
| L97 volatility | |
|---|---|
| L97 Average Weekly Movement | 20.3% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.7% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: L97's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: L97's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 3,826 | Yu Zhang | www.yonghegroup.cn |
Yonghe Medical Group Co., Ltd. provides hair-related healthcare services in China. The company offers hair transplant, medical hair care, routine hair restoration, and other ancillary services. It also engages provision of hair research and consulting services; and wig business.
Yonghe Medical Group Co., Ltd. Fundamentals Summary
| L97 fundamental statistics | |
|---|---|
| Market cap | €53.16m |
| Earnings (TTM) | -€59.55m |
| Revenue (TTM) | €243.07m |
0.2x
P/S Ratio-0.9x
P/E RatioIs L97 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| L97 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.85b |
| Cost of Revenue | CN¥790.63m |
| Gross Profit | CN¥1.06b |
| Other Expenses | CN¥1.51b |
| Earnings | -CN¥453.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.91 |
| Gross Margin | 57.26% |
| Net Profit Margin | -24.50% |
| Debt/Equity Ratio | 16.5% |
How did L97 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 05:05 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Yonghe Medical Group Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yichi Zhang | China International Capital Corporation Limited |
| Junhao Zhang | Guosen Securities Co., Ltd. |
| Liting Wang | Haitong International Research Limited |